Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
60.60
-0.40 (-0.66%)
Jun 24, 2025, 11:31 AM CET

Gentian Diagnostics ASA Market Cap

Gentian Diagnostics ASA has a market cap or net worth of 940.76 million as of June 24, 2025. Its market cap has increased by 33.19% in one year.

Market Cap
940.76M
Enterprise Value
856.37M
Revenue
158.07M
Ranking
n/a
PE Ratio
19.81
Stock Price
60.60

Market Cap Chart

Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 940.76M, an increase of 224.83%. That is a compound annual growth rate of 14.81%.

History

DateMarket Cap% Change
Jun 23, 2025940.76M55.61%
Dec 30, 2024604.56M-5.54%
Dec 29, 2023640.03M1.22%
Dec 30, 2022632.32M-43.06%
Dec 30, 20211.11B32.20%
Dec 30, 2020839.95M-12.61%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Medistim ASA 3.65B
Nordhealth AS 3.00B
Photocure ASA 1.34B
Vistin Pharma ASA 1.07B
Omda AS 1.03B
Thor Medical ASA 893.40M
ArcticZymes Technologies ASA 858.00M
Lytix Biopharma AS 667.60M
Market Cap Rankings